Sales boost for drugs giant GlaxoSmithKline October 28, 2005 Drugs giants GlaxoSmithKline and AstraZeneca unveiled big rises in sales yesterday with demand for key drugs soaring. GlaxoSmithKline, the larger of the two, said sales of its asthma product Advair and Avandia for diabetes increased 20 per cent and 22 per cent respectively. The British company, whose market capitalisation is £83bn, has seen sales in [...]
Brussels meddlers will ruin the Premiership October 28, 2005 The Barclays Premiership is widely regarded as the best football league in the world. A key ingredient of the Premier League’s success has been its ability to attract the top players. Top stars cost big bucks, and the money that the media companies have pumped in has helped the clubs to compete in the market [...]
Monty is in charge October 28, 2005 Colin Montgomerie finished the first round of the Volvo Masters with a share of the lead and a five-shot advantage over his closest rival for the European Order of Merit title, Michael Campbell. The Scot, who is playing alongside Campbell for the first two days in Valderrama, shot an opening 67 to end the day [...]
In a flush on the fairway October 28, 2005 Card schools and golf clubs are big news for singles right now. Lorraine Adams holds the winning hand for a birdie Would you believe that the most sought-after events this year have been our poker nights and golf days? Even those who don’t know how to play poker or golf are desperate to buy up [...]
A week in the life: Jacqueline Kerr October 28, 2005 Head of mutual funds and life funds investment at Standard Life Over the last two years we have been bullish about equities. They have been on a good run and that reflects the amount of equities we hold in comparison to our other assets. One of my roles is to divide up the asset allocation [...]
Cyprotex gets peer approval October 28, 2005 Marianne Barriaux reports on how the technology and information company, which is trying to test drugs by computer instead of on humans and rats, has had a boost with the news it is to have its results published Cyprotex, the drug discovery technology and information company, has received peer-approved publication of its “virtual human and [...]
Smith & Nephew hit by rejection October 28, 2005 Europe’s largest seller of orthopaedic devices saw its shares tumble to a two-year low after it abandoned producing a key leg ulcer treatment when America turned it down, but its sales are up. Smith & Nephew has abandoned production of a key leg ulcer treatment after it failed to win approval for the American market. [...]
Killing the cure October 28, 2005 Some say British drugs companies should be able to profit in order to reinvest in newer drugs for the greater good. Some say their profits come on the back of scientific fraud. It is perhaps one of the great puzzles of British business. As a nation we spend less on medicines than our European neighbours, [...]
Interregnum on up October 28, 2005 AIM-quoted technology merchant bank Interregnum said that its group turnover soared 112 per cent on last year’s results to £7.98m. The company also said that pre-tax losses were down 34 per cent to £430,000 compared to £650,000 in its 2004 financial year. Interregnum is based in Britain and America and specialises in investment advice in [...]
Hands tied to deal October 28, 2005 Guy Hands has finally taken control of East Surrey Holdings, the utility company he was forced to purchase by the Takeover Panel. Hands’s Terra Firm fund made a 525p-a-share offer for Northern Ireland gas distributor East Surrey in April, but then tried to get out of the deal when the country’s gas regulator said it [...]
